for Veterinary Medicine
Antigen-specific humoral and cellular immune response
We are applying a novel vaccine technology to develop vaccines for Animal Health and Veterinary use. Our vaccines are based on the unique S-TIR™ technology platform, which enables the patient’s immune system to generate a powerful and strong immune response after only one or two injections by breaking tolerance to the specific antigens in a reversible way.
The concept of this Next Generation Vaccine Technology has been proven in non-human primates with different B-cell epitopes, T-cell epitopes and recombinant antigen, respectively.
We are looking for partners to co-develop vaccines for veterinary use.
You may meet us at
19-22 June 2017
6-8 Nov 2017
For further information please contact Gottfried Himmler